Cargando…

Validity of Self-testing at Home With Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Detection by Lateral Flow Immunoassay

BACKGROUND: We explore severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow immunoassay (LFIA) performance under field conditions compared to laboratory-based electrochemiluminescence immunoassay (ECLIA) and live virus neutralization. METHODS: In July 2021, 3758 partici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atchison, Christina J, Moshe, Maya, Brown, Jonathan C, Whitaker, Matthew, Wong, Nathan C K, Bharath, Anil A, McKendry, Rachel A, Darzi, Ara, Ashby, Deborah, Donnelly, Christl A, Riley, Steven, Elliott, Paul, Barclay, Wendy S, Cooke, Graham S, Ward, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384551/ https://www.ncbi.nlm.nih.gov/pubmed/35913410 http://dx.doi.org/10.1093/cid/ciac629

Ejemplares similares

Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers
por: Davies, Bethan, et al.
Publicado: (2021)

Machine learning to support visual auditing of home-based lateral flow immunoassay self-test results for SARS-CoV-2 antibodies
por: Wong, Nathan C. K., et al.
Publicado: (2022)

REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol
por: Riley, Steven, et al.
Publicado: (2021)

Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people: a large community cross-sectional study in England
por: Atchison, Christina J, et al.
Publicado: (2023)

Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults
por: Ward, Helen, et al.
Publicado: (2021)

SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people
por: Whitaker, Matthew, et al.
Publicado: (2023)

SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
por: Ward, Helen, et al.
Publicado: (2021)

Population antibody responses following COVID-19 vaccination in 212,102 individuals
por: Ward, Helen, et al.
Publicado: (2022)

Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England
por: Eales, Oliver, et al.
Publicado: (2023)

Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number
por: Eales, Oliver, et al.
Publicado: (2022)

Trends in SARS-CoV-2 infection prevalence during England’s roadmap out of lockdown, January to July 2021
por: Eales, Oliver, et al.
Publicado: (2022)

Resurgence of SARS-CoV-2: Detection by community viral surveillance
por: Riley, Steven, et al.
Publicado: (2021)

SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2
por: Eales, Oliver, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study
por: Chadeau-Hyam, Marc, et al.
Publicado: (2022)

Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England
por: Elliott, Paul, et al.
Publicado: (2022)

Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England
por: Eales, Oliver, et al.
Publicado: (2022)

Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys
por: Chadeau-Hyam, Marc, et al.
Publicado: (2022)

SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys
por: Chadeau-Hyam, Marc, et al.
Publicado: (2022)

Rapid increase in Omicron infections in England during December 2021: REACT-1 study
por: Elliott, Paul, et al.
Publicado: (2022)

Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England
por: Elliott, Paul, et al.
Publicado: (2022)

Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England
por: Whitaker, Matthew, et al.
Publicado: (2022)

The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021
por: Eales, Oliver, et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy study
por: Cann, Alexandra, et al.
Publicado: (2022)

What is the Role of Lateral Flow Immunoassay for the Diagnosis of Melioidosis?
por: Currie, Bart J, et al.
Publicado: (2022)

Measuring Vaccine Efficacy Against Infection and Disease in Clinical Trials: Sources and Magnitude of Bias in Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy Estimates
por: Williams, Lucy R, et al.
Publicado: (2021)

Persistent COVID-19 symptoms in a community study of 606,434 people in England
por: Whitaker, Matthew, et al.
Publicado: (2022)

Platinum Nanocatalyst Amplification: Redefining the Gold Standard for Lateral Flow Immunoassays with Ultrabroad Dynamic Range
por: Loynachan, Colleen N., et al.
Publicado: (2017)

Usability and Acceptability of Home-based Self-testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies for Population Surveillance
por: Atchison, Christina, et al.
Publicado: (2020)

Long-term health impacts of COVID-19 among 242,712 adults in England
por: Atchison, Christina J., et al.
Publicado: (2023)

Diagnosis of Histoplasmosis Using the MVista Histoplasma Galactomannan Antigen Qualitative Lateral Flow–Based Immunoassay: A Multicenter Study
por: Abdallah, Wassim, et al.
Publicado: (2021)

Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people
por: Elliott, Joshua, et al.
Publicado: (2021)

Cryptococcal and Histoplasma Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx Histoplasma Lateral Flow Assay and IMMY Histoplasma Enzyme Immunoassay
por: Ocansey, Bright K, et al.
Publicado: (2022)

SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study
por: Moshe, Maya, et al.
Publicado: (2021)

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
por: Ndieyira, Joseph W., et al.
Publicado: (2013)

Clinical and Serological Findings of Madariaga and Venezuelan Equine Encephalitis Viral Infections: A Follow-up Study 5 Years After an Outbreak in Panama
por: Carrera, Jean-Paul, et al.
Publicado: (2020)

Cantilever Sensors for Rapid Optical Antimicrobial Sensitivity Testing
por: Bennett, Isabel, et al.
Publicado: (2020)

Delays in Hepatitis B Immunization Series Completion in People With Human Immunodeficiency Virus
por: Sheikh, Daanish, et al.
Publicado: (2023)

Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay( )
por: Sigal, George B, et al.
Publicado: (2022)

Awareness and perceptions of Long COVID among people in the REACT programme: Early insights from a pilot interview study
por: Cooper, Emily, et al.
Publicado: (2023)

Perioperative Intravenous Fluid Therapy for Adults
por: Sweeney, Rob Mac, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ikes7ebka8gu76rmtpdv8cq8su